Average Co-Inventor Count = 10.34
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (23 from 116 patents)
2. Abbvie S.a.r.l. (9 from 15 patents)
3. Abbvie Overseas Sarl (5 from 5 patents)
23 patents:
1. 12472181 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
2. 11564923 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
3. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
9. 10604515 - Heteroaryl substituted pyridines and methods of use
10. 10568867 - Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis
11. 10508111 - 6-[5-amino-6-(2-ethoxyethoxy)-imidazo[4,5-B]pyridin-3-yl]-nicotinonitrile derivatives and their use as IRAK inhibitors
12. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
13. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
14. 10138227 - Heteroaryl substituted pyridines and methods of use
15. 10130622 - Compounds for treatment of cystic fibrosis